Illumina, Inc. (ILU)
FSX
Real-time Data
06:00 AM
Day's Range
174.2452 wk Range
75.83Overview - ILU - Illumina, Inc.
Key Statistics
Valuation
Enterprise Value
25.40B
P/E (Trailing)
‪40.83‬
P/E (Forward)
‪37.41‬
PEG Ratio
‪-5.07‬
Price / Sales (TTM)
‪6.29‬
Price / Book
‪12.13‬
EV / EBITDA
‪25.68‬
Profitability
Profit Margin
‪18.33%‬
Operating Margin
‪21.13%‬
Return on Assets
‪8.66%‬
Return on Equity
‪32.33%‬
Ownership
Shares Outstanding
151.00M
Float
148.47M
Held by Insiders
‪0.19%‬
Held by Institutions
‪105.90%‬
Price stats
Beta
‪1.46‬
50-Day Avg
‪162.66‬
200-Day Avg
‪126.68‬
Dividends
Payout Ratio
‪0.00%‬
Peers - ILU - Illumina, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on FSX.
Profile Summary - ILU - Illumina, Inc.
About
Illumina, Inc. is a life sciences and diagnostics company that develops, manufactures, and markets tools and integrated systems for the analysis of genetic material. Its primary focus is on next-generation sequencing technologies, providing high-throughput and lower-throughput sequencing instruments, consumables, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
